US Stock MarketDetailed Quotes

SWTX SpringWorks Therapeutics

Watchlist
  • 38.300
  • -0.390-1.01%
Close Dec 13 16:00 ET
  • 38.300
  • 0.0000.00%
Post 20:01 ET
2.85BMarket Cap-9.85P/E (TTM)

SpringWorks Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
49.3M
59.73M
21.01M
5.45M
5.45M
0
0
0
0
0
Operating revenue
--49.3M
--40.19M
--21.01M
--5.45M
--5.45M
--0
--0
--0
--0
--0
Cost of revenue
3.34M
2.45M
1.2M
422K
422K
0
0
0
0
Gross profit
45.96M
57.28M
19.8M
5.03M
5.03M
0
0
0
0
Operating expense
23.69%103.9M
23.35%102.2M
46.38%113.74M
24.00%348.04M
31.91%103.49M
17.09%84M
20.06%82.85M
26.40%77.7M
61.80%280.67M
40.61%78.45M
Selling and administrative expenses
32.34%61.6M
23.08%57.84M
36.08%60.11M
46.82%197.55M
47.65%59.84M
30.48%46.55M
51.66%46.99M
61.42%44.18M
87.42%134.55M
53.21%40.53M
-General and administrative expense
32.34%61.6M
23.08%57.84M
36.08%60.11M
46.82%197.55M
47.65%59.84M
30.48%46.55M
51.66%46.99M
61.42%44.18M
87.42%134.55M
53.21%40.53M
Research and development costs
12.93%42.3M
23.72%44.36M
59.95%53.62M
2.99%150.49M
15.09%43.65M
3.84%37.45M
-5.70%35.86M
-1.70%33.52M
43.71%146.12M
29.25%37.93M
Operating profit
31.03%-57.94M
45.78%-44.92M
-20.89%-93.93M
-22.21%-343.01M
-25.50%-98.46M
-17.09%-84M
-20.06%-82.85M
-26.40%-77.7M
-61.80%-280.67M
-40.61%-78.45M
Net non-operating interest income expense
11.28%6.22M
16.30%6.78M
36.24%7.57M
273.30%22.95M
28.10%5.98M
512.50%5.59M
1,466.67%5.83M
2,706.57%5.56M
1,025.82%6.15M
6,670.42%4.67M
Non-operating interest income
11.28%6.22M
16.30%6.78M
36.24%7.57M
273.30%22.95M
28.10%5.98M
512.50%5.59M
1,466.67%5.83M
2,706.57%5.56M
1,025.82%6.15M
6,670.42%4.67M
Other net income (expense)
-76.66%-1.81M
-97.11%-1.78M
19.80%-1.03M
-74.33%-5.04M
-371.72%-1.84M
34.36%-1.02M
-119.22%-901K
-141.13%-1.28M
-192.51%-2.89M
-89.76%-389K
Earnings from equity interest
-76.66%-1.81M
-97.11%-1.78M
19.80%-1.03M
-74.33%-5.04M
-169.85%-1.84M
31.09%-1.02M
-132.82%-901K
-279.23%-1.28M
-192.51%-2.89M
-125.91%-680K
Income before tax
32.61%-53.53M
48.77%-39.92M
-19.02%-87.39M
-17.19%-325.1M
-27.16%-94.32M
-9.74%-79.44M
-12.85%-77.93M
-18.80%-73.42M
-59.52%-277.42M
-32.29%-74.18M
Income tax
Net income
32.61%-53.53M
48.77%-39.92M
-19.02%-87.39M
-17.19%-325.1M
-27.16%-94.32M
-9.74%-79.44M
-12.85%-77.93M
-18.80%-73.42M
-59.52%-277.42M
-32.29%-74.18M
Net income continuous Operations
32.61%-53.53M
48.77%-39.92M
-19.02%-87.39M
-17.19%-325.1M
-27.16%-94.32M
-9.74%-79.44M
-12.85%-77.93M
-18.80%-73.42M
-59.52%-277.42M
-32.29%-74.18M
Minority interest income
Net income attributable to the parent company
32.61%-53.53M
48.77%-39.92M
-19.02%-87.39M
-17.19%-325.1M
-27.16%-94.32M
-9.74%-79.44M
-12.85%-77.93M
-18.80%-73.42M
-59.52%-277.42M
-32.29%-74.18M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
32.61%-53.53M
48.77%-39.92M
-19.02%-87.39M
-17.19%-325.1M
-27.16%-94.32M
-9.74%-79.44M
-12.85%-77.93M
-18.80%-73.42M
-59.52%-277.42M
-32.29%-74.18M
Basic earnings per share
43.31%-0.72
56.80%-0.54
0.00%-1.18
1.15%-5.15
-23.93%-1.45
7.30%-1.27
11.35%-1.25
6.35%-1.18
-45.13%-5.21
-0.86%-1.17
Diluted earnings per share
43.31%-0.72
56.80%-0.54
0.00%-1.18
1.15%-5.15
-23.93%-1.45
7.30%-1.27
11.35%-1.25
6.35%-1.18
-45.13%-5.21
-0.86%-1.17
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 49.3M59.73M21.01M5.45M5.45M00000
Operating revenue --49.3M--40.19M--21.01M--5.45M--5.45M--0--0--0--0--0
Cost of revenue 3.34M2.45M1.2M422K422K0000
Gross profit 45.96M57.28M19.8M5.03M5.03M0000
Operating expense 23.69%103.9M23.35%102.2M46.38%113.74M24.00%348.04M31.91%103.49M17.09%84M20.06%82.85M26.40%77.7M61.80%280.67M40.61%78.45M
Selling and administrative expenses 32.34%61.6M23.08%57.84M36.08%60.11M46.82%197.55M47.65%59.84M30.48%46.55M51.66%46.99M61.42%44.18M87.42%134.55M53.21%40.53M
-General and administrative expense 32.34%61.6M23.08%57.84M36.08%60.11M46.82%197.55M47.65%59.84M30.48%46.55M51.66%46.99M61.42%44.18M87.42%134.55M53.21%40.53M
Research and development costs 12.93%42.3M23.72%44.36M59.95%53.62M2.99%150.49M15.09%43.65M3.84%37.45M-5.70%35.86M-1.70%33.52M43.71%146.12M29.25%37.93M
Operating profit 31.03%-57.94M45.78%-44.92M-20.89%-93.93M-22.21%-343.01M-25.50%-98.46M-17.09%-84M-20.06%-82.85M-26.40%-77.7M-61.80%-280.67M-40.61%-78.45M
Net non-operating interest income expense 11.28%6.22M16.30%6.78M36.24%7.57M273.30%22.95M28.10%5.98M512.50%5.59M1,466.67%5.83M2,706.57%5.56M1,025.82%6.15M6,670.42%4.67M
Non-operating interest income 11.28%6.22M16.30%6.78M36.24%7.57M273.30%22.95M28.10%5.98M512.50%5.59M1,466.67%5.83M2,706.57%5.56M1,025.82%6.15M6,670.42%4.67M
Other net income (expense) -76.66%-1.81M-97.11%-1.78M19.80%-1.03M-74.33%-5.04M-371.72%-1.84M34.36%-1.02M-119.22%-901K-141.13%-1.28M-192.51%-2.89M-89.76%-389K
Earnings from equity interest -76.66%-1.81M-97.11%-1.78M19.80%-1.03M-74.33%-5.04M-169.85%-1.84M31.09%-1.02M-132.82%-901K-279.23%-1.28M-192.51%-2.89M-125.91%-680K
Income before tax 32.61%-53.53M48.77%-39.92M-19.02%-87.39M-17.19%-325.1M-27.16%-94.32M-9.74%-79.44M-12.85%-77.93M-18.80%-73.42M-59.52%-277.42M-32.29%-74.18M
Income tax
Net income 32.61%-53.53M48.77%-39.92M-19.02%-87.39M-17.19%-325.1M-27.16%-94.32M-9.74%-79.44M-12.85%-77.93M-18.80%-73.42M-59.52%-277.42M-32.29%-74.18M
Net income continuous Operations 32.61%-53.53M48.77%-39.92M-19.02%-87.39M-17.19%-325.1M-27.16%-94.32M-9.74%-79.44M-12.85%-77.93M-18.80%-73.42M-59.52%-277.42M-32.29%-74.18M
Minority interest income
Net income attributable to the parent company 32.61%-53.53M48.77%-39.92M-19.02%-87.39M-17.19%-325.1M-27.16%-94.32M-9.74%-79.44M-12.85%-77.93M-18.80%-73.42M-59.52%-277.42M-32.29%-74.18M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 32.61%-53.53M48.77%-39.92M-19.02%-87.39M-17.19%-325.1M-27.16%-94.32M-9.74%-79.44M-12.85%-77.93M-18.80%-73.42M-59.52%-277.42M-32.29%-74.18M
Basic earnings per share 43.31%-0.7256.80%-0.540.00%-1.181.15%-5.15-23.93%-1.457.30%-1.2711.35%-1.256.35%-1.18-45.13%-5.21-0.86%-1.17
Diluted earnings per share 43.31%-0.7256.80%-0.540.00%-1.181.15%-5.15-23.93%-1.457.30%-1.2711.35%-1.256.35%-1.18-45.13%-5.21-0.86%-1.17
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+4.34%
MicroStrategy
MSTR
+4.20%
MARA Holdings
MARA
+0.66%
Apple
AAPL
+0.07%
Microsoft
MSFT
-0.51%

Unlock the Full List